Company Filing History:
Years Active: 2009
Title: Akemi Nagao: Innovator in Anti-HIV Compounds
Introduction
Akemi Nagao is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HIV. Her innovative work has led to the creation of a unique compound that holds promise in the fight against this virus.
Latest Patents
Akemi Nagao holds a patent for a 4-oxoquinoline compound and its use as an HIV integrase inhibitor. This invention provides a compound with anti-HIV activity, specifically targeting integrase inhibitory activity. The patent describes a 4-oxoquinoline compound represented by a specific formula, along with its pharmaceutically acceptable salts. The invention also encompasses a pharmaceutical composition that includes this compound, which can be used as an integrase inhibitor, antiviral agent, and anti-HIV agent. This compound can be utilized in multiple drug therapies alongside other anti-HIV agents.
Career Highlights
Akemi Nagao is associated with Japan Tobacco Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective solutions for combating HIV, showcasing her dedication to public health and innovation.
Collaborations
She collaborates with notable colleagues, including Motohide Satoh and Takashi Matsuda, who contribute to her research endeavors. Their combined expertise enhances the potential impact of her inventions in the pharmaceutical industry.
Conclusion
Akemi Nagao's contributions to the field of anti-HIV compounds highlight her role as a leading inventor in pharmaceutical innovation. Her work not only advances scientific knowledge but also offers hope for improved treatments for those affected by HIV.